Moderna says its experimental mRNA influenza vaccine, mRNA-1010, showed more than 30% greater relative vaccine efficacy against influenza A than a licensed egg-based flu shot in a large Phase 3 trial ...

Center for Biologics Evaluation and Research (CBER) issued Moderna a refusal-to-file letter for its mRNA influenza vaccine, mRNA-1010. Two weeks later, under mounting pressure from the scientific ...

The effectiveness of this season’s flu vaccine in Canada is 40% against medically attended infection with influenza A (H3N2) ...

Flu season is not over yet, experts warn. Is there a second wave coming? Here's how to protect yourself as influenza keeps spreading.

The 2024-2025 flu season resulted in 266 pediatric deaths, with 90% of the children who died being eligible for a flu vaccine ...

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune system that help to protect against infection varied greatly depending on the ...

Since being sworn in as Health and Human Services (HHS) secretary, Robert F. Kennedy Jr has repeatedly tried to undermine ...

Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna ...

The 2024-2025 influenza season saw high severity, with 56 million symptomatic cases and 770,000 hospitalizations, mainly affecting older adults. Older adults accounted for 77% of hospitalizations, ...

A new initiative provides clinicians with evidence-based assessments of respiratory vaccines to guide clinical decisions for the 2026-2027 season.

Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...